Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
10.05
-0.07 (-0.70%)
Nov 5, 2024, 11:10 AM EST - Market open
Cybin Employees
Cybin had 50 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
50
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,145,508
Market Cap
204.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 50 | 0 | - |
| Mar 31, 2023 | 50 | 0 | - |
| Mar 31, 2022 | 50 | 12 | 31.58% |
| Mar 31, 2021 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Inogen | 834 |
| Adaptimmune Therapeutics | 449 |
| Caribou Biosciences | 158 |
| Kodiak Sciences | 111 |
| Nanobiotix | 102 |
| Fulcrum Therapeutics | 76 |
| Orchestra BioMed Holdings | 56 |
| Corbus Pharmaceuticals Holdings | 19 |
CYBN News
- 5 days ago - Cybin to Participate at the 2024 Milken Institute Future of Health Summit - Business Wire
- 12 days ago - Cybin Announces Grant of First U.S. Composition of Matter Patent in Support of its CYB005 Phenethylamines Program - Business Wire
- 17 days ago - Undercovered Dozen: Endava, Cross Country Healthcare, Cybin, Equinor + - Seeking Alpha
- 20 days ago - Cybin: Top Value Psychedelic Stock - Seeking Alpha
- 4 weeks ago - Cybin to Participate in Water Tower Research Fireside Chat on October 8, 2024 - Business Wire
- 5 weeks ago - Cybin Expands Clinical Team to Support CYB003 Phase 3 Program - Business Wire
- 5 weeks ago - Water Tower Research Publishes Initiation of Coverage Report on Cybin, Inc., “A Leader in Novel Neuropsychiatry Therapeutics” - GlobeNewsWire
- 6 weeks ago - Cybin to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Business Wire